Stockreport

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A [Financial Post (Toronto, Ontario, Canada)]

XORTX Therapeutics Inc.  (XRTX) 
PDF CALGARY, Alberta, Sept. 12, 2024 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“ XORTX ” or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage cl [Read more]